State Medicaid programs must cover medication assisted treatment under a new mandatory benefit that takes effect today.

The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 added the benefit to increase access to evidenced-based treatment for opioid use disorder for Medicaid beneficiaries.

Specifically, states must cover all forms of drugs and biologicals that the Food and Drug Administration has approved or licensed for MAT to treat OUD, the Centers for Medicare & Medicaid Services said today in a reminder notice

 

Related News Articles

Headline
The Department of Health and Human Services July 2 announced it will provide Medicaid and Children's Health Insurance Program coverage to incarcerated people…
Headline
The Medicaid and CHIP Payment and Access Commission (MACPAC) June 11 released its June report to Congress. The first chapter focuses on improving the…
Headline
A report released May 29 by the Government Accountability Office found a lack of state oversight on Medicaid managed care plans’ use of prior authorization for…
Headline
The Centers for Medicare & Medicaid Services is seeking public comments until July 22 on the information requirements associated with attestation…
Headline
The Centers for Medicare & Medicaid Services recently announced the approval of Delaware and Tennessee as the first states to provide diapers to children…
Headline
The Centers for Medicare & Medicaid Services May 9 announced an extension of unwinding flexibilities to support state efforts to protect the continuity of…